Inogen (INGN) | Stock Overview & Key Data
Inogen Performance Comparison
Stock Range
Today's Range
Low: $8.36
High: $8.75
on October 6, 2025
52 Week Range
Low: $5.70
High: $12.91
on May 15, 2025
on January 30, 2025
All-Time High: $287.79 on September 10, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$235.3M
EPS
-1.06
P/E Ratio (TTM)
-5.69
Forward P/E
-5.58
P/B Ratio
1.17
PEG Ratio
0.15
Div. Yield
N/A
ROE
-13.46%
Beta
1.810
Debt to Equity
9.54
Financial Highlights
Profitability
Gross Margin
44.80%
Operating Margin
-6.64%
Profit Margin
-7.58%
Returns and Earnings
Return on Assets (TTM)
-6.24%
Return on Equity (TTM)
-13.46%
EBITDA
$-10.2M
Net Income (TTM)
$-26.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$14.37
Quarterly Revenue Growth (YoY)
4.00%
Quarterly Earnings Growth (YoY)
3.96%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Inogen INGN | 235.33M Micro-cap | 5.23% | 9.77% | 15.49% | 22.70% | -5.88% | -5.15% | -60.68% | -72.14% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.78% | 1.82% | 0.11% | 2.25% | 18.64% | 19.49% | 32.22% | 22.75% |
| Boston Scientific BSX | 144.20B Large-cap | -0.88% | -9.50% | -6.71% | -1.20% | 8.88% | 15.12% | 144.77% | 136.56% |
| Monogram MGRM | 248.68M Micro-cap | 3.38% | 1.66% | 110.69% | 125.46% | 156.72% | 163.36% | -54.74% | -54.74% |
| TriSalus Life TLSI | 232.86M Micro-cap | -1.70% | -7.23% | -8.88% | -11.49% | -7.23% | 1.54% | -53.57% | -55.23% |
| CVRx CVRX | 227.78M Micro-cap | 15.36% | 11.38% | 32.37% | -29.01% | -35.86% | -0.80% | -11.66% | -65.79% |
Ownership & Short Interest
Insider Ownership
12.08%
Institutional Ownership
74.73%
Shares Short
768K
Short Ratio
4.08
Short % of Shares Outstanding
2.87%
Average 10-Day Volume
182K
Average 90-Day Volume
199K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INGN's 52-week high and low?
- In the last 52 weeks, Inogen reached a high of $12.91 (on January 30, 2025) and a low of $5.70 (on May 15, 2025).
- What is the market cap and P/E ratio for INGN?
- Curious about Inogen's size and valuation? Its market capitalization stands at 235.33M. When it comes to valuation, the P/E ratio (trailing twelve months) is -5.69, and the forward P/E (looking ahead) is -5.58.
- Does INGN pay dividends? If so, what's the yield?
- As for dividends, Inogen isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Inogen's main competitors or similar companies to consider before investing?
When looking at Inogen, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 19.49% 32.22% Boston Scientific
BSX144.20B Healthcare Medical Devices 15.12% 144.77% Monogram
MGRM248.68M Healthcare Medical Devices 163.36% -54.74% TriSalus Life
TLSI232.86M Healthcare Medical Devices 1.54% -53.57% CVRx
CVRX227.78M Healthcare Medical Devices -0.80% -11.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Inogen Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Inogen's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -13.46%, the Debt to Equity ratio from the most recent quarter is 9.54, and its Gross Profit Margin stands at 44.80%.
- What is the recent revenue and earnings growth for INGN?
- Looking at Inogen's growth, its revenue over the trailing twelve months (TTM) was $343M. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.00%, and quarterly earnings saw a YoY growth of 3.96%.
- How much of INGN stock is held by insiders and institutions?
- Wondering who owns Inogen stock? Company insiders (like executives and directors) hold about 12.08% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 74.73%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.